CIN Special Report: Part II, Treatments Ready to Eradicate Pre-Cervical Cancer

Part II of the report identifies several disruptive technologies that may overcome the challenges of mainstream treatments.

Read more »

CIN Special Report: Part I, Can a Dangerous Pre-Cancer Threat Be Tamed?

In response to some recent successes by several companies operating in the cervical cancer space, we are issuing a two-part special report exploring pre-cervical cancer and CIN.

Read more »

Will Contrast-Induced Nephropathy Kill You?

Contrast-induced nephropathy (CIN) is a form of acute renal failure precipitated by exposure to these radiocontrast agents. In other words, it is hospital-acquired. The question is: will it kill you?

Read more »